An up-to-date review on ashwagandha clinical research studies with Chris Kilham - video

There is value in conducting multiple studies related to the same ingredient for the specified health conditions. Chris Kilham, a.k.a. “The Medicine Hunter” spoke with us at SupplySide West 2018 about four studies pending publication related to KSM-66 ashwagandha, and the process that drives credible publication.

December 2, 2018

Conducting clinical studies on an ingredient is a rigorous process that requires more than correct modeling, observable and measurable outcomes.  Credible studies require exhaustive peer review prior to publication, a process that bears no relationship to commercial outcomes.  Join us as Chris Kilham provides an early view at condition specific clinical studies on ashwagandha pending publication.

Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.

You May Also Like